Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc trimmed its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 8.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 297,715 shares of the company's stock after selling 28,975 shares during the period. Ensign Peak Advisors Inc owned 0.16% of Doximity worth $15,895,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Barclays PLC grew its position in Doximity by 60.5% during the 3rd quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after purchasing an additional 20,125 shares during the period. Franklin Resources Inc. grew its position in Doximity by 564.1% during the 3rd quarter. Franklin Resources Inc. now owns 83,098 shares of the company's stock worth $3,487,000 after purchasing an additional 70,585 shares during the period. Nordea Investment Management AB grew its position in Doximity by 6.2% during the 4th quarter. Nordea Investment Management AB now owns 52,176 shares of the company's stock worth $2,815,000 after purchasing an additional 3,053 shares during the period. Wedmont Private Capital acquired a new stake in Doximity during the 4th quarter worth about $298,000. Finally, FNY Investment Advisers LLC acquired a new stake in Doximity during the 4th quarter worth about $613,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. KeyCorp cut their price target on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Morgan Stanley cut their price target on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 24th. Truist Financial cut their price target on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Needham & Company LLC increased their price target on Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Finally, Raymond James restated an "outperform" rating and set a $83.00 target price (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $65.39.

Doximity Trading Down 0.4%

Shares of Doximity stock opened at $59.10 on Monday. The firm has a market capitalization of $11.03 billion, a PE ratio of 59.10, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The firm's 50-day moving average price is $57.99 and its 200 day moving average price is $57.36.

Insider Activity at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares in the company, valued at $946,062.74. This trade represents a 10.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares of the company's stock, valued at $20,440,552.95. This represents a 11.19% decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by corporate insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.